Nanhua Futures Co., Ltd. 南華期貨股 份有限公司 （股 份 代 號：2691） （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司， 中 文 公 司 名 稱 為 南 華 期 貨 股 份 有 限 公 司，通 過 我 們 的 香 港 附 屬 公 司 在 香 港 以 橫 華 國 際 的 名 義 開 展 業 務） 董事名單及其角色與職能 南 華 期 貨 股 份 有 限 公 司 的 董 事（「董 事」）會（「董事會」）成 員 載 列 如 下： 執行董事 非執行董事 呂躍龍先生 徐文財博士 胡天高先生 厲寶平先生 孫穎婷女士 獨立非執行董事 徐林博士 劉玉龍博士 李晶女士 – 1 – 附 註： 羅旭峰博士 – 2 – 董 事 會 有 五 個 委 員 會。下 表 載 列 各名董事於該等委員會 中 的 任 職 情 況。 董事委員會 董 事 審計委員會 薪酬與考核 委員會 提名委員會 戰略委員會 風險管理 委員會 羅旭峰博士 M C C 呂躍龍先生 M 徐文財博士 M M 胡天高先生 M 厲寶平先生 M 孫穎婷女士 M 徐林博士 M C 劉玉龍博士 M C 李晶女士 C M M ...

南華期貨股份有限公司 章 程 | 第一章 | 總 | | | 則 | 1 | | | --- | --- | --- | --- | --- | --- | --- | | 第二章 | | 經營宗旨和範圍 | | | 3 | | | 第三章 | 股 | 份 | | | 3 | | | 第一節 | | 股份發行 | | | 3 | | | 第二節 | | 股份增減和回購 | | | 5 | | | 第三節 | | 股份轉讓 | | | 6 | | | 第四章 | | 股東和股東會 | | | 8 | | | 第一節 | | 股東的一般規定 | | | 8 | | | 第二節 | | 控股股東和實際控制人 | | | 13 | | | 第三節 | | 股東會的一般規定 | | | 15 | | | 第四節 | | 股東會的召集 | | | 17 | | | 第五節 | | 股東會的提案與通知 | | | 19 | | | 第六節 | | 股東會的召開 | | | 22 | | | 第七節 | | 股東會的表決和決議 | | | 26 | | | 第五章 | | 董事和董事會 | | | 31 | | | 第一節 ...

New IPOs - The largest biotech IPO in Hong Kong for 2025 is initiated by Insilico Medicine (03696), which boasts the fastest global progress in AI drug development [1] - Lin Qingxuan (02657) will conduct its IPO from December 18 to December 23, attracting cornerstone investors like Fidelity [1] - Woan Robotics (06600) is set to launch its IPO during the same period, with an expected listing date of December 30 [1] - Meilian Holdings (02671) and Wuyi Vision (06651) will also hold their IPOs from December 18 to December 23, both expected to list on December 30 [1] - Xun Ce (03317) will follow the same IPO schedule, with a listing anticipated on December 30 [1] - Zhihui Mining (02546) achieved a remarkable 5248.15 times subscription in its public offering, with a listing date of December 19 [1] - China National Airlines (00753) plans to invest in Shenzhen Airlines' equity financing, with Kunhang Investment, a state-owned entity, being shortlisted [1] - Sensetime-W (00020) intends to place 1.75 billion new Class B shares, aiming to raise approximately HKD 3.146 billion [1] - Fosun Pharma (02196) is enhancing its overseas innovative drug strategy by signing a cooperation and option agreement with Clavis Bio [1] - WuXi AppTec (02359) invested around EUR 30 million to acquire a 3.22% stake in a French biopharmaceutical fund [1] - Minhua Holdings (01999) plans to acquire 100% equity in the American soft furniture company Gainline Recline Intermediate Corp [1] Share Buybacks - Tencent Holdings (00700) repurchased 1.055 million shares for HKD 636 million on December 18 [2] - Xiaomi Group-W (01810) spent HKD 151 million to buy back 3.75 million shares on the same day [2] - COSCO Shipping Holdings (01919) repurchased 5.9 million shares for HKD 80.557 million [2] - Country Garden Services (06098) bought back 2.7 million shares for HKD 17.136 million [2] - Jiangsu Ninghu Expressway (00177) saw an increase of 52.862 million shares by Yunsong Capital [2]

Core Viewpoint - The Hong Kong stock market is becoming a significant platform for financial institutions to expand globally, with Nanhua Futures set to list on December 22, marking a new phase of development through its "A+H" dual capital platform [1] Group 1: Company Overview - Nanhua Futures, established in 1996, is one of the first companies in China's futures industry and focuses on core businesses in futures and derivatives, becoming a comprehensive global financial service platform [2] - According to Frost & Sullivan, Nanhua Futures ranks eighth among all futures companies in China by total revenue in 2024 and holds the top position among non-financial institution-related futures companies [2] Group 2: Service Offerings - Nanhua Futures has built a comprehensive service system covering the futures and derivatives value chain, including domestic futures brokerage, risk management services, wealth management, and overseas financial services [3] - The product portfolio includes various asset classes such as agricultural products, industrial products, energy, metals, stocks, and fixed income securities, catering to diverse needs of industrial clients, financial institutions, and individual investors [3] Group 3: Global Expansion and Performance - Since 2006, Nanhua Futures has actively pursued internationalization, establishing a business network across major financial centers including Hong Kong, Chicago, Singapore, and London, holding 17 overseas exchange memberships and 14 clearing seats [4] - The number of registered clients in domestic futures brokerage increased from 4,266 in 2022 to 5,279 by mid-2025, while the number of registered financial institution clients rose from 1,140 to 1,872 [4] - Client equity in domestic futures brokerage reached 31.6 billion yuan by the end of 2024, a 65.4% increase from 2022, significantly exceeding the industry’s 1.9% compound annual growth rate [4] Group 4: Financial Performance - Nanhua Futures achieved steady growth in profits, with annual profits increasing from 246 million yuan in 2022 to 458 million yuan in 2024, reflecting a compound annual growth rate of 36.5% [5] - Total assets grew from 34.189 billion yuan at the end of 2022 to 48.863 billion yuan by the end of 2024, with a compound annual growth rate of 19.5% [5] - Return on equity (ROE) improved from 7.75% in 2022 to 11.71% in 2024, with a figure of 5.51% for the first half of 2025 [5] Group 5: Future Outlook - The Chinese futures market is the largest commodity market globally, and with the increasing pace of Chinese enterprises going global, Nanhua Futures is positioned for broader development prospects [6] - The company plans to use the net proceeds from its H-share listing to strengthen its capital base in overseas markets, enhancing its global service network [6] - Nanhua Futures is expected to benefit from market opening incentives and continue leading in the global financial services sector while providing long-term value returns to investors [6]

该信息由智通财经网提供 假设全球发售于2025年12月22日(星期一)上午八时正或之前成为无条件，预期H股将于2025年12月22日 (星期一)上午九时正开始在联交所主板买卖。H股将以每手买卖单位500股H股买卖。H股的股份代号为 02691。 智通财经APP讯，南华期货股份(02691)发布公告，于2025年12月18日(星期四)，发售价已厘定为每股H 股12.00港元。 ...

Core Viewpoint - The A+H listing strategy is becoming a consensus among industry leaders, with companies like Nanhua Futures taking significant steps towards internationalization through its H-share listing in Hong Kong, marking a milestone for the Chinese futures industry [1][2]. Group 1: Industry Trends - The A+H listing trend is characterized by leading companies from various sectors, including manufacturing and new energy, actively seeking to expand their international financing channels by listing in Hong Kong [1]. - As of the latest data, 17 A-share companies have successfully issued H-shares in Hong Kong this year, covering key sectors such as electronics, new energy, manufacturing, and finance [1]. Group 2: Company Strategy - Nanhua Futures' H-share listing is a crucial step in its internationalization strategy, having established a service network across major global financial centers since 2006 [2]. - The expected net fundraising amount from the H-share issuance is over 1.4 billion HKD, which will be used to enhance the scale and optimize the structure of its overseas business [2]. Group 3: Business Development - Nanhua Futures reported revenues of 941 million CNY and a net profit of 351 million CNY for the first three quarters of 2025, with total assets reaching 64.079 billion CNY [3]. - The company has achieved significant growth in its overseas business, with revenues increasing from 231 million CNY in 2022 to 654 million CNY in 2024, reflecting a compound annual growth rate of 68.3% [2][3]. Group 4: Market Position and Future Outlook - The Chinese futures market saw a transaction volume of 675 trillion CNY in the first 11 months of 2025, a year-on-year increase of 20.19%, indicating strong demand for hedging and asset allocation [4]. - Nanhua Futures is positioned to leverage its A+H dual capital platform to enhance its core competitiveness and solidify its industry position, benefiting from the Belt and Road Initiative and the accelerated opening of the futures market [4].

格隆汇12月18日丨南华期货股份(02691.HK)公告，于2025年12月18日(星期四)，发售价已厘定为每股H 股12.00港元(不包括1%经纪佣金、0.0027%证监会交易徵费、0.00015%会财局交易徵费及0.00565%联交 所交易费)。 公司预期于2025年12月19日(星期五)，按照招股章程「如何申请香港发售股份－B.公布结果」一节所述 方式，公布国际发售踊跃程度、香港公开发售的申请水平、香港发售股份分配基准及香港公开发售的分 配结果。 假设全球发售于2025年12月22日(星期一)上午八时正或之前成为无条件，预期H股将于2025年12月22日 (星期一)上午九时正开始在联交所主板买卖。H股将以每手买卖单位500股H股买卖。H股的股份代号为 02691。 ...

香 港 交 易 及 結 算 所 有 限 公 司、香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）及 香 港 中 央 結 算 有 限 公 司（「香港結算」）對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 不 會 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 依 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 除 本 公 告 另 有 界 定 者 外，本 公 告 所 用 詞 彙 與 南 華 期 貨 股 份 有 限 公 司（「本 公 司」）日 期 為2025年12月12日 的 招 股 章 程（「招股章程」）所 界 定 者 具 有 相 同 涵 義。 本 公 告 僅 作 說 明 用 途，並 不 構 成 收 購、購 買 或 認 購 任 何 證 券 的 邀 請 或 要 約。本 公 告 並 非 招 股 章 程。有 意 投 資 者 於 決 定 是 否 投 資 於 發 售 股 份 前 應 閱 覽 招 股 章 程，以 獲 得 有 關 下 文 所 述 全 球 發 售 的 詳 細 資 料 ...

Group 1 - Nanhua Futures Co., Ltd. is planning a global offering of 107.659 million H shares, with 10.766 million shares available for public sale in Hong Kong and 96.893 million shares for international sale [1][3] - The offering price is set between HKD 12.00 and HKD 16.00 per share, with a total fundraising amount estimated between HKD 12.92 billion and HKD 17.23 billion [3][4] - The company aims to use approximately 30% of the net proceeds to enhance its capital base in Hong Kong and establish a subsidiary in Malaysia, with similar allocations for operations in the UK, the US, and Singapore [4] Group 2 - The IPO is scheduled from December 12 to December 17, 2025, with the listing date set for December 22, 2025 [3] - Nanhua Futures is ranked 8th among all futures companies in China by total revenue and 1st among non-financial institution-related futures companies according to a Frost & Sullivan report [5] - The shareholder structure post-IPO indicates that Hengdian Holdings will control approximately 65.43% of the shares, with other A-share and H-share holders holding 19.57% and 15.00% respectively [4][5]

南華期貨股份有限公司 Nanhua Futures Co., Ltd. 股份代號：2691 （於中華人民共和國註冊成立的股份有限公司， 中文公司名稱為南華期貨股份有限公司，在香港以橫華國際的名義開展業務） 獨家保薦人、保薦人兼整體協調人、 聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人 整體協調人、聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人 聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人 聯席賬簿管理人及聯席牽頭經辦人 富 強 證 券 聯席牽頭經辦人 FORTUNE (HK) SECURITIES Nanhua Futures Co., Ltd. 南華期貨股份有限公司 Nanhua Futures Co., Ltd. 全 球 發 售 重要提示 閣下如對本招股章程的任何內容有任何疑問，應尋求獨立專業意見。 Nanhua Futures Co., Ltd. 南華期貨股份有限公司 （於中華人民共和國註冊成立的股份有限公司， 中文公司名稱為南華期貨股份有限公司，通過我們的香港附屬公司 在香港以橫華國際的名義開展業務） 全球發售 | 全球發售的發售股份數目 | ： | 107,659,000股H股（視乎超額配股權行 ...